Carregant...
Attitudes toward prevention of mtDNA-related diseases through oocyte mitochondrial replacement therapy
STUDY QUESTION: Among women who carry pathogenic mitochondrial DNA (mtDNA) point mutations and healthy oocyte donors, what are the levels of support for developing oocyte mitochondrial replacement therapy (OMRT) to prevent transmission of mtDNA mutations? SUMMARY ANSWER: The majority of mtDNA carrie...
Guardat en:
| Publicat a: | Hum Reprod |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840023/ https://ncbi.nlm.nih.gov/pubmed/26936885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dew033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|